Oliveira DHF de, Amador AE, Oliveira CA de, Sá FHA e, Silva RA da, Gonçalves J, et al. SEMAGLUTIDE AND TIRZEPATIDE IN THE TREATMENT OF OBESITY: BENEFITS, RISKS, AND CLINICAL PERSPECTIVES OF GLP-1 RECEPTOR AGONISTS. REASE [Internet]. 2026 Jun. 26 [cited 2026 Oct. 9];12(6):1-17. Available from: https://periodicorease.pro.br/rease/article/view/28619